News Update: Shares of ImmunoGen, Inc. Up After 40% Plunge from Friday
Shares of ImmunoGen, Inc. (NASDAQ:IMGN) were up 10% earlier Monday to $5.66, reports Market Watch. Shares of the company dove 40% last Friday after the accelerated approval of the Roche Holding Ltd.-developed breast cancer treatment, T-DM1, was denied by the US Food and Drug Administration. Roche will now have to wait until mid-2012 to re-apply for approval. SmarTrend currently has ImmunoGen in a Downtrend and is monitoring these developments to alert subscribers to any change of trend. Shares of the pharmaceuticals company continue to trade up 11.05% Monday afternoon at $5.73.
Categories: Breast Cancer Treatment Tags: after, Friday, From, ImmunoGen, Inc., News, plunge, Shares, Update
Lander Energy Corporation to Acquire Valentus Medical Technologies Inc.
Lander Energy Corporation to Acquire Valentus Medical Technologies Inc.
TORONTO, ONTARIO– – LANDER ENERGY CORPORATION , is pleased to announce that it has entered into a share exchange agreement with Valentus Medical Technologies Inc. with respect to a proposed business transaction .
Read more on CCNMatthews via Yahoo! Finance
Categories: Breast Cancer Screening Tags: Acquire, Corporation, Energy, Inc., Lander, Medical, Technologies, Valentus
Breast Cancer Help, Inc. Documentary (Bay Shore, New York)
Breast Cancer Help, Inc. is a not-for-profit grass roots organization with a focus on action and advocacy to eradicate breast cancer. Founded in 1994 by Lorraine Pace, a breast cancer survivor, and Father Thomas Arnao, the group promotes education and awarenessof breast cancer issues on Long Island and elsewhere in New York State.
Categories: Breast Cancer Survivors Tags: breast, cancer, Documentary, help, Inc., Shore, York
Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement
Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement
Tigris Pharmaceuticals, Inc., a privately held drug development company, announced today that it has completed a private placement of Series C Convertible Preferred Stock resulting in gross proceeds of approximately $6.5 million. Â The financing, which was led by Mr.
Read more on PR Newswire via Yahoo! Finance
Categories: High Risk Breast Cancer Tags: $6.5, Completes, Inc., million, Pharmaceuticals, Placement, private, Tigris
AVEO Pharmaceuticals, Inc. Appoints Michael P. Bailey to the Newly Created Position of Chief Commercial Officer
AVEO Pharmaceuticals, Inc. Appoints Michael P. Bailey to the Newly Created Position of Chief Commercial Officer
CAMBRIDGE, Mass.—-AVEO Pharmaceuticals, Inc. , a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the appointment of Michael P.
Read more on Business Wire via Yahoo! Finance
Categories: High Risk Breast Cancer Tags: Appoints, AVEO, Bailey, chief, Commercial, Created, Inc., Michael, newly, officer, Pharmaceuticals, position